acute lymphoblastic leukaemia | Action Medical Research

acute lymphoblastic leukaemia

Childhood leukaemia: developing a new treatment to overcome drug resistance

Research date: 1 November 2018 - 31 October 2021
Grant amount: £208,120.00

Leukaemia is the most common cancer affecting children and young people, affecting around 500 families in the UK each year.1 Up to one in five of these children will have a fast-developing form of the disease called T-cell acute lymphoblastic leukaemia (T-ALL).2 Thankfully, most are cured after treatment – but for those children where the disease...

Acute lymphoblastic leukaemia: making treatment even better

Research date: 11 April 2016 - 10 April 2019
Grant amount: £199,465.00

Around 300 children develop a type of cancer called acute lymphoblastic leukaemia (ALL) each year in the UK.1 This cancer is most common in young children who are less than five years old. Most children with ALL are cured. However, treatment has side effects and some children still lose their lives. Dr Owen Williams, of University College London’s...

Other related information

Improving treatment for children with leukaemia

Posted: 12 September 2016 15:29 pm
Action funding is helping a research team in their bid to find new, more targeted drugs to treat the most common type of cancer to affect children. Acute lymphoblastic leukaemia is an aggressive cancer that develops rapidly.Thanks to medical advances already made, most children have a high chance of being cured. Their treatment, however, will be hard...
Help us spread the word